Author:
Rapoport Bernardo Leon,Aapro Matti,Paesmans Marianne,van Eeden Ronwyn,Smit Teresa,Krendyukov Andriy,Klastersky Jean
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Oncology
Reference27 articles.
1. Dale DC. Colony-stimulating factors for the management of neutropenia in cancer patients. Drugs. 2002;62(Suppl 1):1–15.
2. Klastersky J, de Naurois J, Rolston K, Rapoport B, Maschmeyer G, Aapro M, et al. Management of febrile neutropaenia: ESMO Clinical Practice Guidelines. Ann Oncol. 2016;27(Suppl 5):v111–8.
3. Renner P, Milazzo S, Liu JP, Zwahlen M, Birkmann J, Horneber M. Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile neutropenia in breast cancer patients. Cochrane Database Syst Rev. 2012;10:CD007913.
4. Weycker D, Li X, Edelsberg J, Barron R, Kartashov A, Xu H, et al. Risk and consequences of chemotherapy-induced febrile neutropenia in patients with metastatic solid tumors. J Oncol Pract. 2015;11:47–54.
5. NCCN.org. Myeloid growth factors. In: NCCN guidelines for treatment of Cancer by site. National Comprehensive Cancer Network. 2017.
https://www.nccn.org/professionals/physician_gls/f_guidelines.asp
. Accessed 11 Aug 2017.
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献